Monitor future 6-K filings for actual repurchase activity and upcoming quarterly results to assess revenue trends. The repurchase program signals management's confidence but does not change the fundamental picture of declining revenues.
Price Chart
Executive Summary
BioNTech announced a new $1.0 billion ADS repurchase program authorized through May 6, 2027, to be funded from existing cash. The program is designed to enhance capital efficiency and support long-term value creation, but it does not offset the company's declining revenue trend.
Key Facts
- Up to $1.0 billion in ADS repurchases authorized.
- Program expires May 6, 2027.
- Repurchases will be funded from existing cash.
- ADSs repurchased will be used to satisfy ordinary course obligations.
Financial Impact
$1.0 billion share repurchase authorization, representing approximately 4.2% of market cap.
Risk Factors
- Repurchase execution depends on market conditions and may not materialize.
- Program does not address underlying revenue decline from COVID-19 vaccine demand.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001776985-26-000033 |
| Document: a99120260507_bntxxsbbxenxf.htm | 0001776985-26-000033 |
| Document: 0001776985-26-000033-index-headers.html | 0001776985-26-000033 |
| Document: 0001776985-26-000033-index.html | 0001776985-26-000033 |
| Document: 0001776985-26-000033.txt | 0001776985-26-000033 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 6-K | $98.86 $98.00 | ▼ −0.87% | ▼ −0.98% | $96.61 (−2.28%) |
Sep 14, 2026 18d ago | Press Release | $98.86 $98.00 | ▼ −0.87% | ▼ −0.98% | $96.61 (−2.28%) |
Aug 28, 2026 5w ago | 6-K | $102.08 $103.76 | ▼ −1.65% | ▼ −1.54% | $96.61 (+5.36%) |
Aug 20, 2026 6w ago | 6-K | $110.89 $111.40 | ▲ +0.46% | ▼ −0.65% | $96.61 (−12.88%) |
Aug 11, 2026 7w ago | Institutional Cluster | $92.80 $92.75 | ▼ −0.05% | ▲ +0.35% | $96.61 (+4.10%) |
Aug 4, 2026 8w ago | 6-K | $91.35 $92.80 | ▼ −1.59% | ▼ −1.69% | $96.61 (−5.75%) |
Aug 3, 2026 8w ago | 6-K | $92.25 $92.80 | ▲ +0.60% | ▼ −1.43% | $96.61 (+4.72%) |
Aug 3, 2026 8w ago | Press Release | $92.25 $92.80 | ▲ +0.60% | ▼ −1.43% | $96.61 (+4.72%) |
Jul 29, 2026 9w ago | 6-K | $92.85 $91.19 | ▼ −1.79% | ▼ −5.41% | $96.61 (+4.04%) |
Jun 8, 2026 16w ago | 6-K | $85.50 $90.80 | ▲ +6.20% | ▲ +4.09% | $96.61 (+12.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access